VIVA 23: DETOUR 1 and DETOUR2: PQ Bypass System for Percutaneous Femoropopliteal Bypass скачать в хорошем качестве

VIVA 23: DETOUR 1 and DETOUR2: PQ Bypass System for Percutaneous Femoropopliteal Bypass

We are joined virtually by Dr Sean Lyden (Cleveland Clinic, US) to discuss the findings of a pooled analysis of the DETOUR1 and DETOUR2 studies, which clinically investigated a device intended to improve blood flow in patients with peripheral arterial disease due to femoropopliteal chronic total occlusions. Results suggest that at 2 years, the PQ bypass system is a safe and effective percutaneous treatment option for patients with longer, severely calcified lesions. Interview Questions: -What are the unmet needs for PAD patients with symptomatic femoropoliteal chronic total occlusions? -Could you tell us about the unique features of the PQ Bypass System? -What was the study design and patient population? -What were the key results? -What are your take-home messages? -What further study is needed? Recorded remotely from Ohio, 2023. Visit Radcliffe Cardiology: https://www.radcliffecardiology.com/?... This content is intended for healthcare professionals only. Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster. Like us on Facebook:   / radcliffecardiology   Follow us on X: https://x.com/radcliffeCARDIO